Premium
Compromised blood–brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension
Author(s) -
Biancardi V. C.,
Stern J. E.
Publication year - 2015
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jp271584
Subject(s) - circumventricular organs , angiotensin ii , blood–brain barrier , rostral ventrolateral medulla , subfornical organ , hypothalamus , renin–angiotensin system , area postrema , medicine , blood pressure , endocrinology , context (archaeology) , central nervous system , neuroscience , chemistry , biology , heart rate , paleontology
Angiotensin II (AngII) is a pivotal peptide implicated in the regulation of blood pressure. In addition to its systemic vascular and renal effects, AngII acts centrally to modulate the activities of neuroendocrine and sympathetic neuronal networks, influencing in turn sympatho‐humoral outflows to the circulation. Moreover, a large body of evidence supports AngII signalling dysregulation as a key mechanism contributing to exacerbated sympathoexcitation during hypertension. Due to its hydrophilic actions, circulating AngII does not cross the blood–brain barrier (BBB), signalling to the brain via the circumventricular organs which lack a tight BBB. In this review, we present and discuss recent studies from our laboratory showing that elevated circulating levels of AngII during hypertension result in disruption of the BBB integrity, allowing access of circulating AngII to critical sympathoexcitatory brain centres such as the paraventricular nucleus of the hypothalamus and the rostral ventrolateral medulla. We propose the novel hypothesis that AngII‐driven BBB breakdown constitutes a complementary mechanism by which circulating AngII, working in tandem with the central renin–angiotensin system, further exacerbates sympatho‐humoral activation during hypertension. These results are discussed within the context of a growing body of evidence in the literature supporting AngII as a pro‐inflammatory signal, and brain microglia as key cell targets mediating central AngII actions during hypertension.